The Chart of the Day belongs to ImmunoGen (IMGN). I found the drug stock by using Barchart to sort today's Top Stocks to Own list first by the highest Weighted Alpha, then I used the Flipchart feature to review the charts for consistent price appreciation.Since the Trend Spotter signaled a buy on 12/14 the stock gained 46.72%.

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.

Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

• 195.23+ Weighted Alpha
• 100% technical buy signals
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 12 new highs and up 40.49% in the last month
• Relative Strength Index 79.03%
• Technical support level at 9.03
• Recently traded at 9.88 with a 50 day moving average of 7.05

Fundamental factors;

• Market Cap $1.22 billion
• Wall Street analysts issued 5 strong buy, 1 buy 3 hold and 1 sell recommendation on the stock
• The individual investors on Motley Fool that follow the stock vote 322 to 25 that the stock will beat the market